正文
《医学前沿(英文)》 >> 2021年 第15卷 第2期 doi: 10.1007/s11684-020-0795-4
Overcoming resistance to endocrine therapy in hormone receptor-positive human epidermal growth factor receptor 2-negative (HR
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College, Beijing 100021, China
摘要
关键词
endocrine-resistant ; HR+/HER2- advanced breast cancer ; randomized clinical trials ; meta-analysis ; targeted therapy
正文